Human Hepatoma Cell Lines

  • Jennifer J. Alexander


A major biological component of cancer is that of uncontrolled growth. Viable cells do not maintain stasis with the organ of origin although they may retain some of its specialized metabolic functions. This seemingly unlimited growth potential in vivo should be transplantable to in vitro conditions where repeatable and comparative studies could be carried out on many different cell lines, originating from tumors of the same histological type but from different individuals. However, the establishment of human tumors as permanent cell lines in vitro is a rare event.


Human Hepatoma Hepatoma Cell Line Human Hepatoma Cell Line Hepatoma Patient Adenine Arabinoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fogh J, Trempe G (1975) New human tumor cell lines. In: Fogh J (ed) Human tumor cells in vitro. Plenum, London, pp 115–159CrossRefGoogle Scholar
  2. 2.
    Chen J, Tang S, Chu T, Shen T (1962) Preliminary report on the establishment of a strain of human liver cancer cells in vitro. In: VIII International Cancer Congress Abstracts. Moscow, p 136Google Scholar
  3. 3.
    Aden D, Fogel A, Plotkin S, Damjanov I, Knowles B (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615–616PubMedCrossRefGoogle Scholar
  4. 4.
    Doi I (1976) Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67:1–10PubMedGoogle Scholar
  5. 5.
    Prozesky O, Brits C, Grabow W (1973) In vitro culture of cell lines from Australia Antigen positive and negative hepatoma patients. In: Saunders S, Terblanche J (eds) Liver. Pitman, London, pp 358–360Google Scholar
  6. 6.
    Doi I, Namba M, Sato J (1975) Establishment and some biological characteristics of human hepatoma cell lines. Gann 66:385–392Google Scholar
  7. 7.
    Alexander J, Bey E, Geddes E, Lecatsas G (1976) Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50:2124–2128PubMedGoogle Scholar
  8. 8.
    Chen R, Zhu D, Ye X, Shen D, Lu R (1980) Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro. Scientia Sinica 23:236–247PubMedGoogle Scholar
  9. 9.
    Das P, Nayak N, Tsiquaye K, Zuckerman A (1980) Establishment of a human hepatocellular carcinoma cell line releasing hepatitis B virus surface antigen. Br J Exp Pathol 61:648–654PubMedGoogle Scholar
  10. 10.
    Huh N, Utakoji T (1981) Production of HBsantigen by two new hepatoma cell lines and its enhancement by dexamethasone. Gann 72:178–179PubMedGoogle Scholar
  11. 11.
    Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 42:3858–3863PubMedGoogle Scholar
  12. 12.
    He L, Isselbacher K, Wands J, Goodman H, Shih C, Quaroni A (1984) Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro 29:493–504CrossRefGoogle Scholar
  13. 13.
    Laohathai K, Bhamarapravati N (1985) Culturing of human hepatocellular carcinoma: A simple and reproducible method. A J P 118:203–208Google Scholar
  14. 14.
    Matsuura H (1983) Primary cultured cells and an established cell line of human hepatocellular carcinomas. Acta Med Okayama 37:341–352PubMedGoogle Scholar
  15. 15.
    Lin J-H, Tong M, Stevenson D (1984) A new human hepatocellular carcinoma cell line secreting hepatitis B surface antigen and alpha-fetoprotein. In: Vyas G, Deinstag J, Hoofnagle J (eds) Viral hepatitis and liver disease. Grune and Stratton, Orlando, p 673Google Scholar
  16. 16.
    Bassendine M, Curtin N, Ince P, Gaunt K, Fowler M, James O (1984) Establishment of a cell line (PLC/NUT/1) containing integrated hepatitis B virus (HBV) DNA from a hormone associated human primary liver cell cancer. In: Vyas G, Deinstag J, Hoofnagle J, (eds) Viral hepatitis and liver disease. Grune and Stratton, Orlando, p 625Google Scholar
  17. 17.
    Watanabe T, Morizane T, Tsuchimoto K, Inagaki Y, Munakata Y, Nakamura T, Kumagai N, Tsuchiaja M (1983) Establishment of a cell line (HCCM) from a human hepatocellular carcinoma. Int J Cancer 32:141–146PubMedCrossRefGoogle Scholar
  18. 8.
    Chang C, Lin Y, O’Lee T-W, Chow C-K, Lee T-S, Liu T-S, P’Eng F-K, Chen T-Y, Hu C-P (1983) Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol 3:1133–1137PubMedGoogle Scholar
  19. 9.
    Yaginuma K, Kobayashi M, Yoshida E, Koike K (1985) Hepatitis B virus integration in hepatocellular carcinoma DNA: Duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci USA 82:4458–4462PubMedCrossRefGoogle Scholar
  20. 20.
    Knowles B, Howe C, Aden D (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins of hepatitis B surface antigen. Science 209:497–499PubMedCrossRefGoogle Scholar
  21. 21.
    Bassendine M, Arborgh B, Shipton N, Monjardino J, Aranguibel F, Thomas H, Sherlock S (1980) Hepatitis B surface antigen and alphafetoprotein secreting human primary liver cancer in athymic mice. Gastroenterology 79: 528–532PubMedGoogle Scholar
  22. 22.
    Nakabayashi H, Taketa K, Yamane T, Oda M, Sato J (1985) Hormonal control of α-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res 45:6379–6383PubMedGoogle Scholar
  23. 23.
    Knowles B, Searls D, Aden D (1984) Human hepatoma derived cell lines. In: Chisari F (ed) Advances in hepatitis research. Masson, New York, pp 196–202Google Scholar
  24. 24.
    Gerber M, Garfinkel E, Hirschman S, Thung S, Panagiotatos T (1981) Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol 126:1085–1089PubMedGoogle Scholar
  25. 25.
    Robinson K, Bey E, Alexander J, Gear J (1976) Chromosome analyses of two recently established human tumor cell lines derived from a carcinoma of the oesophagus and a primary liver tumor. S Afr J Med Sci 41:285–295PubMedGoogle Scholar
  26. 26.
    Simon D, Aden D, Knowles B (1982) Chromosomes of human carcinoma cell lines. Int J Cancer 30:27–33PubMedCrossRefGoogle Scholar
  27. 27.
    Pinto M, Bey E, Bernstein R (1985) The PLC/PRF/5 human hepatoma cell line: 1. Reevaluation of karyotype. Cancer Genetics Cytogenetics 18:11–18CrossRefGoogle Scholar
  28. 28.
    Marquardt O, Freytag von Loringhoven A, Miller K, Desmyter J (1984) Two types of cells are present in in vitro and in vivo cultures of PLC/ PRF/5 cells. In: Vyas G, Deinstag J, Hoofnagle J (eds) Viral hepatitis and liver disease. Grune and Stratton, Orlando, p 669Google Scholar
  29. 29.
    Koshy R, Maupas Ph, Muller R, Hofschneider PH (1981) Detection of hepatitis B virus-specific DNA in genomes of human hepatocellular carcinoma and liver cirrhosis tissue. J Gen Virol 57:95–102PubMedCrossRefGoogle Scholar
  30. 30.
    Marion P, Salazar F, Alexander J, Robinson W (1980) State of hepatitis B viral DNA in a human hepatoma cell line. J Virol 33:795–806PubMedGoogle Scholar
  31. 31.
    Koike K, Kobayashi M, Mizusawa H, Yoshida E, Yaginuma K, Taira M (1983) Rearrangement of the surface antigen gene of hepatitis B virus integrated in the human hepatoma cell lines. Nuc Acid Res 11: 5391–5402CrossRefGoogle Scholar
  32. 32.
    Stannard L, Alexander J (1977) Electron microscopy of HBsAg from human hepatoma cell line. Lancet 2:713–714CrossRefGoogle Scholar
  33. 33.
    Alexander J, Macnab G, Saunders R (1978) Studies on in vitro production of hepatitis B surface antigen by a human hepatoma cell line. In: Pollard M (ed) Perspectives in virology, vol. 10. Raven, New York, pp 103–120Google Scholar
  34. 34.
    Marion P, Salazar F, Alexander J, Robinson W (1979) Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell line. J Virol 32:796–802PubMedGoogle Scholar
  35. 35.
    Aoki N, Thung S, Gerber M (1982) Ultrastructural analysis of hepatitis B surface antigen production in vitro. Lab Invest 47:465–470PubMedGoogle Scholar
  36. 36.
    Alexander J, van der Merwe C, Saunders R, McElligott S, Desmyter J (1982) A comparison between in vitro experiments with a hepatoma cell line and in vivo studies. Hepatology 2:92S–96SGoogle Scholar
  37. 37.
    Saunders R, Alexander J (1977) HBsAg production by parental and cloned cell cultures. Lancet 2:714Google Scholar
  38. 38.
    Wen Y, Copeland J, Mann G, Howard C, Zuckerman A (1981) Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line. Arch Virol 68:157–163PubMedCrossRefGoogle Scholar
  39. 39.
    Twist E, Clark H, Aden D, Knowles B, Plotkin S (1981) Integration pattern of hepatitis B virus DNA sequences in human hepatoma cell lines. J Virol 37:239–243PubMedGoogle Scholar
  40. 40.
    Desmyter J, De Groote G, Bradburne A, Desmet V, Edy V, Billiau A, De Somer P, Mortelans J (1976) Administration of human fibroblast interferon in chronic hepatitis B infection. Lancet 2:645–647PubMedCrossRefGoogle Scholar
  41. 41.
    Desmyter J, De Groote G, Ray M, Bradburne A, Desmet V, De Somer P, Alexander J (1981) Tumorigenicity and interferon properties of PLC/ PRF/5 human hepatoma cell line. Prog Med Virol 27:103–108PubMedGoogle Scholar
  42. 42.
    Nakajima Y, Kuwata T, Tomita Y, Okuda K (1982) Effect of interferon on the production of HBsAg and induction of an antiviral state in human hepatoma cell line PLC/PRF/5. Microbiol Immunol 26: 705–712PubMedGoogle Scholar
  43. 43.
    Alexander J, McElligott S, Saunders R (1978) Antibody to hepatitis B surface antigen is not cytotoxic to antigen-secreting hepatocytes. S Afr Med J 54:973–974PubMedGoogle Scholar
  44. 44.
    Shouval D, Wands J, Zurawski V, Isselbacher K, Shafritz D (1982) Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. Proc Natl Acad Sci USA 79:650–654PubMedCrossRefGoogle Scholar
  45. 45.
    Shouval D, Shafritz D, Zurawski V, Isselbacher K, Wands J (1982) Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus. Nature 298:567–569PubMedCrossRefGoogle Scholar
  46. 46.
    Lemon S, Bancroft W (1979) Lack of specific effect of adenine arabinoside, human interferon and ribavirin on in vitro production of hepatitis B surface antigen. J Infect Dis 140:798–801PubMedCrossRefGoogle Scholar
  47. 47.
    Clementi M, Bagnarella P, Pauri P, Calegari L (1984) Modulation of production of hepatitis B surface antigen by a human hepatoma cell line. J Med Virol 13:117–123PubMedCrossRefGoogle Scholar
  48. 48.
    Pottage J, Kessler H (1985) Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole. J Med Virol 16:275–281PubMedCrossRefGoogle Scholar
  49. 49.
    Marshall J, Coulepsis A, Pringle R, Dimitrakakis M, Gust I (1983) The effect of glucocorticoid hormones on release of HBsAg from PLC/PRF/5 (Alexander) hepatoma cells. Acta Virol 27:429–433PubMedGoogle Scholar
  50. 50.
    Barin F, Goudeau A, Brechot C, Romet-Lemonne J, Sureau C, Lesage G (1983) Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5). Develop Biol Standard 54:81–92Google Scholar
  51. 51.
    Daemer R, Feinstone S, Alexander J, Tully J, Tully W, London W, Wong W, Purcell R (1980) PLC/PRF/5 (Alexander) Hepatoma cell line. Studies on infectivity and synthesis of hepatitis B virus antigens. Infect Immun 30: 607–611PubMedGoogle Scholar
  52. 52.
    Tabor E, Copeland J, Mann G, Howard C, Skelly J, Snoy P, Zuckerman A, Gerety J (1981) Nondetection of infectious hepatitis B virus in a human hepatoma cell line producing hepatitis B surface antigen. Intervirol 15: 82–86CrossRefGoogle Scholar
  53. 53.
    Rutter W, Zeimer M, Ou J, Shaul Y, Laub O, Garcia P, Standring D (1984) Transcription units of hepatitis B virus genes and structure and expression of integrated viral sequences. In: Vyas G, Deinstag J, Hoofnagle J (ed) Viral hepatitis and liver disease. Grune and Stratton, Orlando, pp 67–86Google Scholar
  54. 54.
    Miller R, Robinson W (1983) Integrated hepatitis B virus DNA sequences specifying the major viral core polypeptide are methylated in PLC/PRF/5 cells. Proc Natl Acad Sci USA 80:2534–2538PubMedCrossRefGoogle Scholar
  55. 55.
    Aspinall S, Alexander J (1985) Hepatitis B virus gene expression in two cell lines, one derived from a natural human infection, the other experimentally infected in vitro. S Afr Med J 68:751–754PubMedGoogle Scholar
  56. 56.
    Yoakum G, Korba B, Lechner J, Tokiwa T, Gazdar A, Seeley T, Siegel M, Leeman L, Autrup H, Harris C (1983) High frequency transfection and cytopathology of the hepatitis B virus core antigen gene in human cells. Science 222:385–389PubMedCrossRefGoogle Scholar
  57. 57.
    Marquardt O, Freytag von Loringhoven A, Frosner G (1984) PLC/PRF/5 cells grown as nude mouse tumor express HBV core antigen genes. In: Vyas G, Deinstag J, Hoofnagle J (eds) Viral hepatitis and liver disease. Grune and Stratton, Orlando, p 669Google Scholar
  58. 58.
    Zaslavsky V, Marquardt O, Wong T-K, Hofschneider PH (1980) Hepatitis B virus (HBV)-specific structures found in cytoplasmic extracts of cells producing HBV surface antigen (HBsAg) in vitro. J Gen Virol 51:341–349PubMedCrossRefGoogle Scholar
  59. 59.
    Moriarty A, Alexander H, Lerner R, Thornton G (1985) Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227:429–433PubMedCrossRefGoogle Scholar
  60. 60.
    Wen Y-M, Mitamura K, Merchant B, Tang Z, Purcell R (1983) Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA. Infec Immun 39:1361–1367Google Scholar
  61. 61.
    Simon D, Searls D, Cao Y, Sun K, Knowles B (1985) Chromosomal site of hepatitis B virus (HBV) integration in a human hepatocellular carcinoma-derived cell line. Cytogenet Cell Genet 39:116–120PubMedCrossRefGoogle Scholar
  62. 62.
    Bowcock A, Pinto M, Bey E, Kuyl J, Dusheiko G, Bernstein R (1985) The PLC/PRF/5 hepatoma cell line: II. Chromosomal assignment of hepatitis B virus integration sites. Cancer Genetics Cytogenet 18:19–26CrossRefGoogle Scholar
  63. 63.
    Rogler C, Sherman M, Su C, Shafritz D, Summers J, Shows T, Henderson A, Kew M (1985) Deletion in chromosome11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science 230:319–322PubMedCrossRefGoogle Scholar
  64. 64.
    Freytag von Loringhoven A, Koch S, Hofschneider PH, Koshy R (1985) Co-transcribed 3′ host sequences augment expression of integrated hepatitis B virus DNA. EMBO J 4:249–255Google Scholar
  65. 65.
    Brechot C, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286: 533–535PubMedCrossRefGoogle Scholar
  66. 66.
    Edman J, Gray P, Valenzuela P, Rall L, Rutter W (1980) Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 286: 535–538PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 1987

Authors and Affiliations

  • Jennifer J. Alexander
    • 1
  1. 1.Department of MicrobiologyUniversity of the WitwatersrandRepublic of South Africa

Personalised recommendations